Retraction Note to: FOXC2 promotes colorectal cancer metastasis by directly targeting MET

被引：0
|
作者：
Y-M Cui
H-L Jiao
Y-P Ye
C-M Chen
J-X Wang
N. Tang
T-T Li
J. Lin
L. Qi
P. Wu
S-Y Wang
M-R He
L. Liang
X-W Bian
W-T Liao
Y-Q Ding
机构：
[1] Southern Medical University,Department of Pathology, Nanfang Hospital
[2] Southern Medical University,Department of Pathology, School of Basic Medical Sciences
[3] Guangdong Provincial Key Laboratory of Molecular Tumor Pathology,Guangdong Provincial Key Laboratory of Gastroenterology and Department of Gastroenterology, Nanfang Hospital
[4] Southern Medical University,Institute of Pathology and Southwest Cancer Center, Southwest Hospital
[5] Third Military Medical University,undefined
来源：
Oncogene | 2022年 / 41卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2529 / 2529
相关论文
共 50 条
  • [21] FOXC2 variation in breast cancer survivors with secondary lymphedema
    Miller, RL
    Feingold, E
    Lorenzo, K
    Levinson, KL
    Dunlap, JW
    Kimak, MA
    Lawrence, EC
    Soran, A
    Vogel, VG
    Esman, JH
    Ferrell, RE
    Finegold, DN
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 524 - 524
  • [22] Glioblastoma-associated microglia-derived exosomal circKIF18A promotes angiogenesis by targeting FOXC2
    Yang Jiang
    Junshuang Zhao
    Jinkun Xu
    Haiying Zhang
    Jinpeng Zhou
    Hao Li
    Guoqing Zhang
    Kai Xu
    Zhitao Jing
    Oncogene, 2022, 41 : 3461 - 3473
  • [23] FOXC2 is overexpressed and participates in cell proliferation in ovarian cancer
    Quan, Yuan
    Quan, Zhe
    Zheng, Chunhua
    Deng, Weiguo
    Meng, Fanhui
    Fu, Yan
    TRANSLATIONAL CANCER RESEARCH, 2015, 4 (05) : 453 - 459
  • [24] The FOXC2 Transcription Factor: A Master Regulator of Chemoresistance in Cancer
    Hargadon, Kristian M.
    Strong, Elijah W.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [25] Glioblastoma-associated microglia-derived exosomal circKIF18A promotes angiogenesis by targeting FOXC2
    Jiang, Yang
    Zhao, Junshuang
    Xu, Jinkun
    Zhang, Haiying
    Zhou, Jinpeng
    Li, Hao
    Zhang, Guoqing
    Xu, Kai
    Jing, Zhitao
    ONCOGENE, 2022, 41 (26) : 3461 - 3473
  • [26] FOXC2 promotes vasculogenic mimicry and resistance to anti-angiogenic therapy
    Cannell, Ian G.
    Sawicka, Kirsty
    Pearsall, Isabella
    Wild, Sophia A.
    Deighton, Lauren
    Pearsall, Sarah M.
    Lerda, Giulia
    Joud, Fadwa
    Khan, Showkhin
    Bruna, Alejandra
    Simpson, Kathryn L.
    Mulvey, Claire M.
    Nugent, Fiona
    Bressan, Dario
    Dive, Caroline
    Caldas, Carlos
    Hannon, Gregory J.
    CELL REPORTS, 2023, 42 (08):
  • [27] FOXC2 positively regulates YAP signaling and promotes the glycolysis of nasopharyngeal carcinoma
    Song, Lijuan
    Tang, Hongbo
    Liao, Wenjing
    Luo, Xinggu
    Li, Yanmei
    Chen, Tao
    Zhang, Xiaowen
    EXPERIMENTAL CELL RESEARCH, 2017, 357 (01) : 17 - 24
  • [28] The FOXC2 Transcription Factor: A Master Regulator of Chemoresistance in Cancer
    Hargadon, Kristian M.
    Strong, Elijah W.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [29] FOXC2 expression and epithelial-mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer
    Borretzen, Astrid
    Gravdal, Karsten
    Haukaas, Svein A.
    Beisland, Christian
    Akslen, Lars A.
    Halvorsen, Ole J.
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2019, 5 (04): : 272 - 286
  • [30] miR-424-5p promotes the proliferation and metastasis of colorectal cancer by directly targeting SCN4B
    Dai, Weijie
    Zhou, Jiajie
    Wang, Han
    Zhang, Menghui
    Yang, Xiaozhong
    Song, Wei
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (01)
12345